The US government yesterday approved the use of Taxol - a potential cancer fighter derived from the bark of Pacific Yew trees - for ovarian cancer patients who have not responded to other treatments , Reuter reports from Washington . Taxol is being studied for a number of other cancer uses including breast , lung and head and neck cancers . The new drug will be marketed by Bristol-Myers Squibb .